Skip to main content

RAYLYTIC

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

RAYLYTIC

{subtitle}

Case Study

Clinical studies are complex and time-consuming, but essential for the advancement of medicine. RAYLYTIC is helping digitize healthcare by using smart digital technologies to simplify the clinical trial process through automation and standardization.

For this company with its team of highly motivated experts, digital health isn’t just a buzzword. Using cloud-based software solutions supported by artificial intelligence (AI), RAYLYTIC makes clinical trial processes easier and more efficient for healthcare companies and medical research institutions.

A variety of factors contributed not only to this digital pioneer being founded in Leipzig, but to its ongoing transition from fledgling start-up to success story:

  • Leipzig’s world-renowned universities and research institutions, particularly in the fields of medical and computer sciences, were a clear plus for the knowledge-based venture
  • The expanding regional pipeline of highly skilled university graduates helped the company recruit the fresh talent necessary for innovation and growth
  • Leipzig’s business development community actively supported the company during its seed and start-up phase. The digital start-up notably received support from Saxony’s Technology Start-Up Fund (TGFS) which is headquartered in Leipzig

The excellent quality of life which Leipzig offers, together with its good infrastructure and central location, daily confirm to the company that it has picked the right place to be.

“Leipzig has become a very attractive location for young companies like ours, with its high quality of life and comparably affordable living costs,”

says RAYLYTIC CEO and founder Frank T. Trautwein. “That’s why our employees have been, and continue to be, committed to Leipzig and to our company’s vision for a digital healthcare future.”

RAYLYTIC is making clinical trial processes simpler and more efficient: Its AI-supported software platform UNITY automatically collects, analyzes and automates medical data – thus helping reduce errors and ensure that clinical trials are successful.

Share

RAYLYTIC

Founded in Leipzig in 2017 with a core team of niche experts, the company has since grown to 50+ employees. Its cloud-based software solutions are designed for the digitalization, automation and standardization of the routine processes associated with clinical trials. Its clinical trial management solutions also include AI-supported systems for image data analysis. Learn more at www.raylytic.com

News

Smart Infrastructure Hub in Leipzig receives a further 1,9 million euros in funding

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

digital-health

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.

More Case Studies

mementor GmbH

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

digital-health

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

Conventional patient care has reached its limits in many areas of the healthcare landscape. Digital pioneer mementor is shaping the future of medicine with evidence-based digital tools which address physical and mental illnesses – safely and effectively.

INNO3 GmbH

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

digital-health

Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers

The healthcare sector is in the midst of a challenging transfor-mation process. INNO3 is re-thinking health by providing the industry with client-focused and sustainability-based solutions to drive and enable innovations that will shape the future.

Back to top